Orange Book product · Generic (ANDA)
ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN ETHYLSUCCINATE
At a glance
Nov 01, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 01, 2019
6 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
ERYTHROMYCIN ETHYLSUCCINATE
Strength
EQ 200MG BASE/5ML
Dosage form
GRANULE
Route
ORAL
TE code
AB
Application
ANDA 211204
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERYTHROMYCIN ETHYLSUCCINATE
- —E.E.S.Brand (NDA)
NDA 050207 · CARNEGIE
- —E.E.S.Brand (NDA)
NDA 050297 · AZURITY
- 2022ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 216212 · CADILA PHARMS LTD
- 2019ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 211991 · PH HEALTH
- 1988ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062847 · AUROBINDO PHARMA USA
- 1987ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062674 · NASKA
- 1985ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062559 · PHARMAFAIR
- 1985ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062558 · PHARMAFAIR
- —ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062055 · ANI PHARMS
- —PEDIAMYCINGeneric (ANDA)
ANDA 062305 · ROSS LABS
- —E-MYCIN EGeneric (ANDA)
ANDA 062198 · PHARMACIA AND UPJOHN
- —E.E.S. 200Generic (ANDA)
ANDA 061639 · ARBOR PHARMS LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
